IBERIABANK Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:IBERIABANK Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1298
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

IBERIABANK Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s IBERIABANK Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by IBERIABANK Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes IBERIABANK Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by IBERIABANK Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on IBERIABANK Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by IBERIABANK Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for IBERIABANK Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about IBERIABANK Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CAPITAL RAISING 49
Capital Raising – Overview 49
Capital Raising – Deal reports 50
Divestments – Deal reports 66
APPENDIX 68
Contact Us 68
About MarketLine Financial Deals Database 68
Deal Definition and Methodology 70
About MarketLine 77

List of Tables
Table 1: IBERIABANK Corporation M&A volume and value trend (2014-YTD2018)
Table 2: IBERIABANK Corporation M&A activity by geography (2014-YTD2018)
Table 3: IBERIABANK Corporation capital raising volume and value trend (2014-YTD2018)
Table 4: IBERIABANK Corporation capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: IBERIABANK Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: IBERIABANK Corporation M&A activity by geography (2014-YTD2018)
Figure 3: IBERIABANK Corporation capital raising volume and value trend (2014-YTD2018)
Figure 4: IBERIABANK Corporation capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[IBERIABANK Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Huhtamaki Oyj:企業の戦略・SWOT・財務情報
    Huhtamaki Oyj - Strategy, SWOT and Corporate Finance Report Summary Huhtamaki Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Woori Bank:戦略・SWOT・企業財務分析
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Advocate Health Care:製薬・医療:M&Aディール及び事業提携情報
    Summary Advocate Health Care (Advocate Health) is a nonprofit health system that provides health care services. It provides health care services such as inpatient acute and non-acute care, primary and specialty physician services and various outpatient services to communities in Illinois. The organi …
  • IRPC Public Company Limited:企業の戦略・SWOT・財務分析
    IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Boursorama Sa:企業の戦略・SWOT・財務分析
    Boursorama Sa - Strategy, SWOT and Corporate Finance Report Summary Boursorama Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cadence Design Systems, Inc. (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems, Inc. (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Storebrand ASA:企業のM&A・事業提携・投資動向
    Storebrand ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Storebrand ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Serodus ASA:製薬・医療:M&Aディール及び事業提携情報
    Summary Serodus ASA (Serodus) is a drug development company that develops treatments for unmet clinical needs in the areas of diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephropathy; SER130AMI, an …
  • Piraeus Bank SA:企業のM&A・事業提携・投資動向
    Piraeus Bank SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Piraeus Bank SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Havfisk ASA:企業の戦略・SWOT・財務分析
    Havfisk ASA - Strategy, SWOT and Corporate Finance Report Summary Havfisk ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cipla Limited:戦略・SWOT・企業財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Scientific Industries Inc (SCND):企業の財務・戦略的SWOT分析
    Summary Scientific Industries Inc (Scientific Industries) is a medical device company that designs and manufactures mixer, shaker and other laboratory products. The company’s product includes vortex mixers and shakers, rotators, rockers and incubators, magnetic stirrers, laboratory balances, force g …
  • Revolution Medicines Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revolution Medicines Inc (Revolution Medicines) is a drug development company that discovers and develops new medicines and therapies for cancer patients. The company’s programs include SHP2 Program, 4EBP1 Program and mTORC1 Program. It develops REVBLOCKS platform, an integrated suite of mod …
  • Janssen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆